Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Khan, Safi U
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis. [electronic resource] - Journal of the American Heart Association 04 2019 - e011581 p. digital
Publication Type: Journal Article; Meta-Analysis; Systematic Review
2047-9980
10.1161/JAHA.118.011581 doi
Antibodies, Monoclonal, Humanized--adverse effects
Anticholesteremic Agents--adverse effects
Cholesterol, LDL--drug effects
Diabetes Mellitus--chemically induced
Ezetimibe--adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
PCSK9 Inhibitors
Randomized Controlled Trials as Topic
Risk Factors
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis. [electronic resource] - Journal of the American Heart Association 04 2019 - e011581 p. digital
Publication Type: Journal Article; Meta-Analysis; Systematic Review
2047-9980
10.1161/JAHA.118.011581 doi
Antibodies, Monoclonal, Humanized--adverse effects
Anticholesteremic Agents--adverse effects
Cholesterol, LDL--drug effects
Diabetes Mellitus--chemically induced
Ezetimibe--adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
PCSK9 Inhibitors
Randomized Controlled Trials as Topic
Risk Factors